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An amplified fragment length polymorphism (AFLP) method was applied to 129 strains representing 24
different Clostridium species, with special emphasis on pathogenic clostridia of medical or veterinary interest,
to assess the potential of AFLP for identification of clostridia. In addition, the ability of the same AFLP
protocol to type clostridia at the strain level was assessed by focusing on Clostridium perfringens strains. All
strains were typeable by AFLP, so the method seemed to overcome the problem of extracellular DNase
production. AFLP differentiated all Clostridium species tested, except for Clostridium ramosum and Clostridium
limosum, which clustered together with a 45% similarity level. Other Clostridium species were divided into
species-specific clusters or occupied separate positions. Wide genetic diversity was observed among Clostridium
botulinum strains, which were divided into seven species-specific clusters. The same AFLP protocol was also
suitable for typing C. perfringens at the strain level. A total of 29 different AFLP types were identified for 37
strains of C. perfringens; strains initially originating from the same isolate showed identical fingerprinting
patterns and were distinguished from unrelated strains. AFLP proved to be a highly reproducible, easy-to-
perform, and relatively fast method which enables high throughput of samples and can serve in the generation
of identification libraries. These results indicate that the AFLP method provides a promising tool for the
identification and characterization of Clostridium species.
The genus Clostridium is a heterogeneous group of bacteria
which currently consists of 181 described species. Clostridia are
widely distributed in the environment as well as in the intesti-
nal tract of humans and of many animals. Several Clostridium
species are pathogenic to humans, domestic animals, or wild-
life and are responsible for well-known clostridial diseases such
as tetanus, gas gangrene, botulism, pseudomembranous colitis,
and food-borne illness (10). In addition, clostridia can be in-
volved in a variety of human infections, such as cholecystitis,
pneumonia, bacteremia, empyema, and abscesses, and can thus
be isolated from various clinical specimens. However, many of
the isolates can be occasional contaminants, or nonpathogenic
clostridia, and may not be involved in the disease process.
Therefore, the reliable identification of clostridia, isolated
from clinical specimens, is important. In addition, a link must
be established between isolated clostridia and pathological
changes.
Despite the clinical significance of clostridia, reliable, prac-
tical, and fast identification methods are few. Although simple
tests can serve to identify most commonly isolated Clostridium
species, the identification of other clostridia by conventional
biochemical testing and gas-liquid chromatography is still la-
borious, expensive, and time-consuming. Furthermore, sev-
eral commercial identification systems for anaerobic bacte-
ria have failed to accurately identify Clostridium species (23,
29, 30, 43). Due to these evident drawbacks of conventional
methods, there is a growing trend toward molecular diag-
nostics of bacteria that are difficult to identify by phenotypic
characters (28, 42).
Amplified fragment length polymorphism (AFLP) is a DNA
fingerprinting method based on the digestion of total DNA
with two restriction enzymes, followed by the ligation of re-
striction site-specific adapters and the amplification of a subset
of fragments by PCR (46). The AFLP approach, using a fluo-
rescently labeled primer and detection of the fragments with
an automated DNA sequencer, allows the use of internal size
markers for accurate band sizing as well as partial automation
and straightforward computer-assisted analysis, which make
AFLP advantageous for the generation of extensive finger-
printing databases.
AFLP has proven to be a useful tool in epidemiological and
outbreak studies (1, 5, 9, 20). In addition to strain typing,
AFLP has been utilized in taxonomic studies. AFLP has been
used to differentiate Aeromonas (16), Acinetobacter (19), Arco-
bacter (36), avian mycoplasma (13), Burkholderia (3), Campy-
lobacter (7, 35), and Xanthomonas (18), and the results appear
to agree closely with results obtained by DNA-DNA hybrid-
ization experiments (2, 3, 16, 38).
AFLP has been used to genotype Clostridium botulinum
(21), Clostridium difficile (24), Clostridium novyi (32), and Clos-
tridium perfringens (31), but the ability of AFLP analysis in
differentiating Clostridium species remains unevaluated. There-
fore, we applied an AFLP protocol previously used to charac-
terize C. botulinum on 24 different Clostridium species, with
special emphasis on pathogenic clostridia of medical or veter-
inary interest, to examine whether AFLP is a suitable tool for
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TABLE 1. List of Clostridium strains used in the study
Species Strain code Origin Sourcea
C. aurantibutyricum ATCC 17777 Type strain DMM
C. baratii CCUG 24033 Type strain DMM
C. bifermentans Cbif patient Patient DMM
1213/00 NDb EVIRA
Cbif 101c ND DFEH
271 ND DFEH
Cbif 9855/69 ND DFEH
C. botulinum type A ATCC 25763 Type strain DFEH
ATCC 3502 ND DFEH
ATCC 7948d Virgin soil IFR
62A (ATCC 7948)d Virgin soil DFEH
NCTC 3806 Peas IFR
C. botulinum type AB NCTC 2916 Home-canned corn IFR
NCFB 3037c Infant botulism IFR
C. botulinum type B ATCC 17841 (p)e ND DFEH
ATCC 17844 (np)e ND DFEH
126 B (p) ND DFEH
CDC 7827 (p) Human stool IFR
KV 40/10 (p) Beeswax DFEH
Eklund 2B (np) Marine sediment DFEH
Prevot 59 (np) ND IFR
Kapchunka B2 (np) Fish IFR
C. botulinum type C ATCC 17782c ND DMM
Cbot 106C c Horse DFEH
Stockholm C ND DFEH
1672 C ND DFEH
C. botulinum type D ATCC 9633 Cattle botulism (lamziekte) DFEH
Gunisson D ND DFEH
C. botulinum type E K-8 Rainbow trout intestines DFEH
K-22 Burbot intestines DFEH
K-25 Burbot surface DFEH
K-35 Vendace DFEH
K-37 Hot smoked whitefish DFEH
K-51 Rainbow trout surface DFEH
K-126 Hot smoked salmon DFEH
31-2570E ND DFEH
C. botulinum type F ATCC 25764 (p)c Crab IFR
ATCC 23387 (np) Marine sediment DFEH
FT 14 (p) ND IFR
Colworth 47 (np) ND IFR
Colworth 195 (np) ND IFR
C. butyricum ATCC 19398 Type strain DMM
Cbutyr 102 ND DFEH
BL-5262-9REc Human IFR
1204 Silage DFEH
C. cadaveris CCUG 24035 Type strain DMM
C. chauvoei 41 ND DFEH
95/1147c ND EVIRA
C. difficile ATCC 9689 Type strain DMM
ATCC 17858 ND DMM
CCUG 19126 Human abdominal wound DMM
C. hastiforme ATCC 33268 Type strain DMM
C. histolyticum ATCC 8034 ND DMM
105009 ND DMM
C. innocuum ATCC 14501 Type strain DMM
C. limosum CCUG 24037 Type strain DMM
C. novyi LV 5536 ND DMM
139/99 ND EVIRA
C. paraputrificum Cparap patient Patient DMM
C. perfringens ATCC 13124d Type strain DMM
ATCC 3624c ND DFEH
ATCC 3626c Intestinal contents of lamb DFEH
NCTC 8237 (ATCC 13124)d Type strain EVIRA
NCTC 3110 ND EVIRA
NCTC 3180d Ovine enterotoxaemia (struck) EVIRA
NCTC 8239c Salt beef DFEH
NCTC 8798 Meat rissole, food poisoning outbreak DFEH
Continued on facing page
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TABLE 1—Continued
Species Strain code Origin Sourcea
NCTC 8346d Sheep EVIRA
NCTC 8084 ND EVIRA
NCTC 10239 ND DFEH
CCUG 44727 ND DFEH
CCUG 2036 (NCTC 3180)d Ovine enterotoxaemia (struck) DFEH
CCUG 2037 (NCTC 8346)c,d Sheep DFEH
CCUG 2038 ND DFEH
88V10-8 Human DFEH
42 ND DFEH
106 ND DFEH
AAD 1527e Antibiotic-associated diarrhea DFEH
SIDS 5-14 Infant intestines DFEH
Cperf 606 ND DFEH
10204 Food DFEH
D9030f Human, food poisoning outbreak DFEH
D903f Human, food poisoning outbreak DFEH
D9032f Human, food poisoning outbreak DFEH
Perf pat Patient DMM
VELL 35/3 ND DMM
SB 3992c ND DMM
4732c Game fry DFEH
108 ND DFEH
15525/88 Human DFEH
15563/88 Human DFEH
F-3686 ND DFEH
88V10-9 Human DFEH
15394/88 Human DFEH
Cperf 103A ND DFEH
Cperf 104D ND DFEH
C. ramosum CCUG 24038 Type strain DMM
C. rectum DSMZ 1295 Type strain DMM
C. septicum ATCC 12464c Type strain DMM
105 ND DFEH
43c ND DFEH
105011c ND DMM
501/96c ND EVIRA
105020 ND DMM
C. sporogenes ATCC 3584 Type strain DMM
ATCC 19404c Gas gangrene DMM
ATCC 25784 Reference strain DMM
AMRI/96 ND DFEH
KL8 Cheese DFEH
KL4 Cheese DFEH
M2843 ND DFEH
M66-7-1 Cheese DFEH
105008 ND DMM
NINF 45 ND DMM
Patient 88 Patient DMM
C. sordellii ATCC 9714c Type strain DMM
NCTC 8780 ND DMM
LV1765/1988 ND DMM
105013c ND DMM
64/97c ND EVIRA
Csord patient Patient DMM
Csord 105 ND DFEH
C. subterminale ATCC 25774c Type strain DMM
C. tertium ATCC 14573c Type strain DMM
ATCC 19405 ND DMM
C. tetani ATCC 19406c Type strain DMM
105012c ND DMM
C. tyrobutyricum 1193 Cheese DFEH
1194 Cheese DFEH
a DFEH, Department of Food and Environmental Hygiene, University of Helsinki, Finland; DMM, Department of Medical Microbiology, University of Turku,
Finland; EVIRA, Finnish Food Safety Authority, Kuopio Research Unit, Finland; IFR, Institute of Food Research, Norwich, England.
b ND, no data available.
c Strains used in reproducibility testing.
d The same strain was also obtained from another culture collection with a different strain code (given in parentheses).
e np, nonproteolytic; p, proteolytic.
f Isolates originating from the same outbreak.
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the identification of clostridia. In addition, we assessed the
ability of the same AFLP protocol to type clostridia at the
strain level by focusing on C. perfringens strains of all five toxin
types.
MATERIALS AND METHODS
Bacterial strains. A total of 129 strains of 24 different Clostridium species from
the Culture Collections of the Department of Food and Environmental Hygiene,
University of Helsinki, Finland; the Department of Medical Microbiology, Uni-
versity of Turku, Finland; the Institute of Food Research, Norwich, United
Kingdom; and the Finnish Food Safety Authority, Kuopio Research Unit, Kuo-
pio, Finland, were studied (Table 1). Strains consisted of type strains (n  18)
and strains originating from diverse sources and locations, including clinical,
environmental, and food samples. Three C. perfringens isolates originated from
the same outbreak and three of the C. perfringens NCTC reference strains
(NCTC 3180, NCTC 8237, and NCTC 8346) were also obtained from another
culture collection with different strain codes (CCUG 2036, ATCC 13124, and
CCUG 2037, respectively).
DNA extraction. Total DNA was extracted as previously described by Hyytia¨ et
al. (17), with slight modifications. Strains were grown in a tryptose-peptone-
glucose-yeast medium (Difco Laboratories, Detroit, MI) under anaerobic con-
ditions at the optimal growth temperature for each strain for 14 to 16 h. The cells
were resuspended with 400 l TE (10 mM Tris-HCl, 1 mM EDTA) and incu-
bated with 7.9 mg/ml lysozyme (Sigma, St. Louis, MO), 159 IU/ml mutanolysin
(Sigma), and 476 g/ml RNase (Sigma) at 37°C with gentle shaking for 15 min
(C. botulinum group I), 2 h (C. botulinum group II), or 1 h (other Clostridium
species). Lysis was completed by adding 52 g/ml proteinase K (Finnzymes,
Espoo, Finland), 0.23 M NaCl, 9.1 mM EDTA, and 0.8% (vol/vol) sodium
dodecyl sulfate. After thorough mixing, the mixture was incubated at 60°C for 1 h
with gentle shaking. Phenol-chloroform-isoamyl alcohol (25:24:1 [vol/vol]) and
chloroform–2-pentanol (24:1 [vol/vol]) extractions were performed, and the
DNA was precipitated with ethanol (95% [vol/vol]), rinsed with 70% ethanol,
and resuspended with 100 l sterile, distilled, deionized water; DNA was stored
at 70°C. DNA concentrations were determined using a BioPhotometer
(Eppendorf, Hamburg, Germany).
AFLP analysis. An AFLP protocol previously used to characterize C. botuli-
num strains (21) was used with some modifications. Total DNA (400 ng) was
digested with 15 U HindIII (New England Biolabs, Beverly, MA) and 15 U
HpyCH4IV (New England Biolabs) in 1 One-Phor-All buffer plus (Amersham
Biosciences, Buckinghamshire, United Kingdom), 5 mM dithiothreitol, and 0.1
mg/ml bovine serum albumin. Restriction site-specific HindIII adapter (0.04 M;
Oligomer, Helsinki, Finland) and HpyCH4IV adapter (0.4 M; Oligomer)
(Table 2) were ligated with 1.1 U T4 DNA ligase (New England Biolabs) in 1
One-Phor-All buffer plus (Amersham Biosciences), 5 mM dithiothreitol, 0.1
mg/ml bovine serum albumin, and 200 M ATP. Samples were stored at 20°C
prior to PCR amplification.
The digested and ligated DNA samples were diluted with sterile, distilled,
deionized water (1:2) and amplified by preselective PCR (72°C for 2 min; 20
cycles of 94°C for 20 s, 56°C for 2 min, and 72°C for 2 min) in a 20-l reaction
mixture containing 4 l of diluted template DNA, 15 l amplification core mix
(Applied Biosystems, Foster City, CA), 25 nM Hind-0 primer (Oligomer), and
125 nM Hpy-0 primer (Oligomer) (Table 2). After preselective amplification, the
templates were diluted with sterile, distilled, deionized water 1:20. Selective
amplification was performed in a 10-l reaction mixture containing 1.5 l of
diluted template, 50 nM 6-carboxyfluorescein (FAM)-labeled Hind-C primer
(Oligomer), 250 nM Hpy-A primer (Oligomer) (Table 2), and 7.5 l amplifica-
tion core mix (Applied Biosystems) (94°C for 2 min; 1 cycle of 94°C for 20 s, 66°C
for 30 s, 72°C for 2 min; then the annealing temperature was lowered by 1°C
each cycle to 56°C [10 cycles], followed by an additional 19 cycles at a 56°C
annealing temperature and a final 30-min extension at 60°C). All PCR am-
plifications were performed with a PTC-200 Peltier thermal cycler (MJ Re-
search, Inc., Waltham, MA).
Selective amplification products (1 l) were mixed with 0.5 l of internal size
standard (GS-500 LIZ; Applied Biosystems) to enable accurate band sizing and
11.5 l Hi-Di formamide (Applied Biosystems) and denatured at 95°C for 2 min.
Denatured fragments were electrophoresed on POP-4 polymer (Applied Biosys-
tems) on an ABI PRISM 310 genetic analyzer (Applied Biosystems) in 1
genetic analyzer buffer with EDTA (Applied Biosystems). The electrophoresis
conditions were 15 kV at 60°C for 28 min. Data preprocessing was performed
using GeneScan 3.7 fragment analysis software (Applied Biosystems).
Reproducibility testing. Reproducibility of the method was determined by
performing duplicate (n 17), triplicate (n 5), fivefold (n 2), or sixfold (n 
1) experiments, including DNA extraction, AFLP analysis, electrophoresis, and
numerical data analysis, with a total of 25 strains representing different Clostrid-
ium species (Table 1). In addition, reproducibility among different data sets was
assessed using C. botulinum type E strain K-51 as an internal reference, which
underwent each step of the DNA extraction and AFLP analysis a total of 11
times, thereby providing a standard for comparison among different data sets.
AFLP pattern analysis. AFLP patterns were analyzed using BioNumerics
software, version 4.5 (Applied Maths, Kortrijk, Belgium), and similarity between
normalized AFLP patterns (range 75 to 450 bp) was calculated with the Pearson
product-moment correlation coefficient. Clustering and construction of dendro-
grams were performed by using the unweighted pair-group method with arith-
metic averages.
RESULTS
All clostridial strains studied were typeable by AFLP. The
enzyme and primer combination used in AFLP analysis gen-
erated evenly distributed banding patterns in the range of 75 to
450 bp. Based on the cluster analysis, the 45% similarity level
served to differentiate Clostridium strains at the species level
(Fig. 1). By this criterion, AFLP analysis divided Clostridium
strains into 21 clusters (I to XXI); 20 of the clusters consisted
of strains belonging to a single species. In addition, eight
strains, which were the only representatives of the particular
species studied, occupied separate positions. AFLP failed,
however, to discriminate between Clostridium ramosum and
Clostridium limosum, which clustered together with a 45%
similarity level (cluster XIV).
In reproducibility testing among different data sets, the in-
ternal reference C. botulinum strain K-51 showed 93% or
higher similarity due to small variations in peak heights. How-
ever, the resulting AFLP banding patterns, measured based on
fragment sizes, remained constant during each separate run. In
addition, after independent repeated experiments in the 25
different Clostridium strains tested, none of the AFLP banding
profiles changed. The 93% cutoff value served to define the
AFLP type of C. perfringens strains.
C. botulinum strains were divided into seven distinct clusters.
Group I (proteolytic) C. botulinum strains were linked together
at a similarity value of 56% (cluster III). Group II (nonpro-
teolytic) C. botulinum strains formed three clusters; cluster XV
consisted of strains of C. botulinum types B and F, whereas C.
botulinum type E strains were divided into clusters XVI and
XVII. C. novyi and group III C. botulinum types C and D
clustered together with a similarity value of 22%. C. novyi
and C. botulinum type D formed single clusters XI and XIII,
TABLE 2. Adapter and primer oligonucleotides used in AFLP
Oligonucleotide Sequence
Adapters
HindIII .......................................5-CTCGTAGACTGCGTACC-3
3-CTGACGCATGGTCGA-5
HpyCH4IV.................................5-GACGATGAGTCCTGAC-3
3-TACTCAGGACTGGC-5
Primers
Hind-0 ........................................5-GACTGCGTACCAGCTT-3
Hpy-0 ..........................................5-CGATGAGTCCTGACCGT-3
Hind-C (FAM labeled) ............5-GACTGCGTACCAGCTTC-3
Hpy-A.........................................5-CGATGAGTCCTGACCGTA-3
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FIG. 1. Reconstructed AFLP banding patterns and a dendrogram of 24 Clostridium species based on AFLP analysis. The cluster containing 37
C. perfringens strains is shaded. A similarity analysis was performed using the Pearson product-moment correlation coefficient, and clustering was
performed by using the unweighted pair-group method with arithmetic averages. Clostridium clusters generated at the 45% similarity level (dashed
line) are marked with Roman numerals (I to XXI). a, serotype of C. botulinum strains; b, the C. botulinum group definition is in parentheses.
VOL. 44, 2006 DIFFERENTIATION OF CLOSTRIDIUM SPECIES BY AFLP 4061
respectively, whereas C. botulinum type C strains were di-
vided into two separate clusters (X and XII). The AFLP
analysis clearly differentiated between C. botulinum group I
and Clostridium sporogenes. However, C. sporogenes and C.
botulinum group I strains were linked together at a similarity
value of 22%.
C. perfringens strains (n  37) clustered together with a
similarity value of 58% (Fig. 1 and 2). Two subclusters of C.
perfringens strains were observed. Strains belonging to subclus-
ters 1 and 2 clustered together with a similarity value of 62%
and 85%, respectively. In subcluster 1, toxin types A, B, C, D,
and E were detected, whereas subcluster 2 consisted only of
strains of toxin type A (Fig. 2). With a 93% cutoff value, C.
perfringens strains were divided into 29 different AFLP types.
However, visual examination of AFLP patterns of C. perfrin-
gens revealed minor fragment differences in strains of AFLP
types aflp3 and aflp5. In three events, the same C. perfringens
strain was obtained from two different commercial culture
collections. The AFLP analysis of these pairs that initially
originate from the same isolate resulted in identical finger-
printing patterns. Identical AFLP profiles were also observed
for isolates originating from the same outbreak.
DISCUSSION
In this present study, we applied AFLP to 24 different Clos-
tridium species and a total of 129 strains. AFLP differentiated
all species tested, except for C. ramosum and C. limosum.
Thirteen species were separated into single species-specific
clusters, and eight strains, which were the only representatives
of those particular species, also occupied separate positions.
Furthermore, C. botulinum strains were divided into seven
species-specific clusters. Although AFLP failed to discriminate
between C. ramosum and C. limosum at the 45% similarity
level, these species were linked together at a relatively low
similarity level of 49%, and the differences between AFLP
patterns were evident in visual examination. Since it is neces-
sary to extend the identification library with several AFLP
patterns of well-defined strains for each species to obtain re-
liable species identification (7), further AFLP analysis on
larger numbers of strains of C. ramosum and C. limosum may
facilitate differentiation between these species as well.
Some Clostridium strains are known to produce extracellular
DNase, which may limit the use of DNA fingerprinting meth-
ods such as pulsed-field gel electrophoresis (PFGE) (11, 25, 41,
44, 45). Since all strains studied were typeable by AFLP, the
AFLP method seemed to overcome the problem of extracel-
lular DNase production. Furthermore, the AFLP method
proved to be highly reproducible and the similarity level of
93% for internal reference strains is in accordance with ear-
lier studies (3, 4, 6, 22, 36). The slight variation seen in peak
heights of AFLP patterns during reproducibility testing may
result from differences in the effectiveness of digestion-ligation
or PCR amplification steps (27). The 93% cutoff value used for
defining the AFLP type of C. perfringens and the 45% similarity
level, which served to differentiate Clostridium strains at the
species level, are in agreement with previous AFLP studies of
different bacteria (6, 22, 39). AFLP also proved to be a rela-
tively fast, easy-to-use method. The AFLP analysis, including
numerical data analysis, can be completed within two working
days when initiated with pure DNA.
The results of the AFLP analysis confirmed the phylogenetic
finding based on 16S rRNA sequencing of three distinct lin-
eages of C. botulinum groups I, II, and III (15). The distribu-
tion of C. botulinum strains in more than one cluster may also
stem from the wide genetic diversity observed among group
II C. botulinum strains. This is in accordance with previous
studies based on PFGE (12) and AFLP (21).
C. sporogenes, which displays high 16S rRNA sequence ho-
mology (15) and DNA relatedness (26) with group I C. botu-
linum types A, B, and F, is considered a nontoxigenic counter-
part of group I C. botulinum. Ghanem et al. (8) also reported
that 17% of C. sporogenes strains were incorrectly identified as
C. botulinum type A or B by cellular fatty acid analysis. The
AFLP results are in agreement with those of previous studies
on the close relationships of C. botulinum group I and C.
sporogenes, since these species were linked together with
AFLP, albeit with a relatively low similarity value. With AFLP,
however, a clear distinction emerged between C. botulinum
group I and C. sporogenes species-specific clusters, indicating
that AFLP analysis is capable of discriminating between these
Clostridium species.
C. novyi type A and C. botulinum types C and D cannot be
differentiated from each other by their phenotypic properties,
and C. novyi type A is considered a nontoxigenic variant of
group III C. botulinum (14). That group III C. botulinum and
C. novyi clustered together with AFLP suggests that they are
closely related. This is in accordance with previous studies
based on 16S rRNA gene sequence analysis, which revealed
that C. novyi type A and C. botulinum types C and D are
grouped as a separate phylogenetic lineage (15). With AFLP,
single species-specific subclusters were observed for C. novyi
and C. botulinum type D, while C. botulinum type C strains
were divided in two separate subclusters. Wide diversity among
C. botulinum type C has also been reported by Nakamura et al.
(34), who found that based on DNA-DNA homology studies,
one strain of C. botulinum type C (Stockholm strain) was more
closely related to a group consisting of C. novyi type B and
Clostridium haemolyticum strains than to the other strains of C.
botulinum type C examined.
Phenotypically, C. bifermentans closely resembles C. sordellii.
The main criterion for the differentiation of these species is the
lack of urease production by C. bifermentans, although re-
searchers have reported urease-negative strains of C. sordellii
(33). In this present study, one of the C. sordellii strains
(LV1765/1988) was urease negative, which could hamper iden-
tification based on phenotypic testing. However, AFLP clearly
differentiated between C. sordellii and C. bifermentans strains.
The AFLP method previously described for the character-
ization of C. botulinum (21) also proved suitable for the char-
acterization of C. perfringens. Although some toxinotype-re-
lated subclustering was observed, in general, AFLP was
deemed unsuitable for differentiation between various toxino-
types of C. perfringens. This finding was expected, since genes
encoding three major toxins of C. perfringens (, ε, and  toxins)
are located on plasmids, thus enabling even toxinotype change
of a strain by loss or acquisition of plasmids (37). The existence
of strains of different toxin types in the same cluster has also
been revealed by multiple-locus variable-number tandem-re-
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FIG. 2. Reconstructed AFLP banding patterns and a dendrogram of 37 Clostridium perfringens strains based on AFLP analysis. A similarity
analysis was performed using the Pearson product-moment correlation coefficient, and clustering was performed by using the unweighted
pair-group method with arithmetic averages. The dashed line shows the cutoff similarity value (93%). a, isolates originating from the same
outbreak.
VOL. 44, 2006 DIFFERENTIATION OF CLOSTRIDIUM SPECIES BY AFLP 4063
peat analysis, suggesting that the acquisition of plasmid-borne
major toxin genes is a rather recent event and that strains of
different toxin types may not have distinct evolutionary histo-
ries (40). Unrelated C. perfringens strains resulted in divergent
AFLP banding patterns, whereas C. perfringens strains initially
originating from the same isolate or from the same outbreak
showed identical fingerprinting patterns, thus indicating that
AFLP is a highly discriminative genotyping method. With
AFLP, we observed excellent typeability; thus, AFLP is an
attractive alternative to PFGE in outbreak situations. In addi-
tion to the high diversity of AFLP profiles of C. perfringens and
C. botulinum, the AFLP patterns of strains of C. bifermentans,
C. septicum, C. sordellii, and C. sporogenes showed substantial
diversity, suggesting that AFLP may be able to subtype these
species at the strain level. Further research is warranted to
evaluate the usefulness of AFLP in epidemiological studies of
these Clostridium species.
We conclude that AFLP is a highly reproducible, easy-to-
use, and relatively fast method which can be applied to differ-
ent clostridia and used for the generation of identification
libraries. Therefore, libraries of AFLP profiles of well-defined
Clostridium strains provide a valuable additional tool in the
identification of Clostridium species. Due to partial automa-
tion, which enables high throughput of samples, AFLP seems
particularly well suited for screening large numbers of isolates.
Moreover, the same protocol can be used in typing at the strain
level. This present study demonstrated the value of AFLP for
distinguishing between strains of C. perfringens, and AFLP can
thus be utilized in epidemiological and outbreak studies of C.
perfringens.
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